Effect of Dialysis-specific Therapeutic Diet on Biochemical Parameters in Dialysis Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Dialysis-specific therapeutic diet: A healthy diet for dialysis patients
Study summary
In patients with kidney failure, disturbances in bone turnover, mineral metabolism, vascular calcification, uremia, inflammation, immunity, metabolomics, nutrition, and gut microbial metabolites are frequent. Unhealthy diet causes altered mineral metabolism, elevated uremic toxin level, immune dysregulation, metabolic abnormalities, inflammation, protein-energy wasting and dysbiosis. The investigators hypothesize that therapeutic diet intervention reverses these uremic complications and thereby reduces cardiovascular risk in patients with kidney failure. In this study, the investigators crafted 4-week dialysis-specific therapeutic diet to illustrate the clinical implications of therapeutic diet for dialysis patients.
Eligibility
Primary outcome measure(s)
- Concentrations of intact fibroblast growth factor 23 (pg/mL) — 4 weeks
Difference in change-from-baseline intact fibroblast growth factor 23 (pg/mL) between therapeutic diet and usual diet
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Far Eastern Memorial Hospital | New Taipei City | Banciao Dist. |
More Far Eastern Memorial Hospital trials in Taiwan
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06377293 on ClinicalTrials.gov ↗ ← All trials in Taiwan